List of companies in Forbion Capital Partners's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
A company developing gene therapies for the treatment of genetic diseases and cancer. | ||||||
A company developing immunotherapy treatments for cancers, infectious and autoimmune diseases | ||||||
Developer of p300/CBP small-molecule inhibitor drug to treat cancer. | ||||||
A company developing and commercializing cancer molecular diagnostics based isolation of exosomes from body fluids. Exosome Diagnostics was founded in 2008. | ||||||
A biotechnology company discovering drugs that target the epitranscriptomics machinery that modifies RNA. | ||||||
Purespring Therapeutics is a gene therapy provider for kidney diseases founded in 2020. | ||||||
AM-Pharma is a biopharmaceutical company developing recombinant human Alkaline Phosphatase (AP) therapeutics, which have the potential to treat patients with Acute Kidney Injury, Inflammatory Bowel Disease and Hypophosphatasia. | ||||||
Oral antifungal therapy developer to treat life-threatening rare fungal infections | ||||||
Replimune Group, Inc. is a clinical-stage biotechnology company. | ||||||
Milestone Pharmaceuticals is a small Molecules founded in 2007. | ||||||
Precirix is a private, clinical-stage biopharmaceutical company dedicated to extending and improving the lives of cancer patients by designing and developing novel radiopharmaceuticals, using camelid-derived single-domain antibodies (sdAb) labeled with radioisotopes. | ||||||
KaNDy Therapeutics is a clinical-stage company focused on optimising the potential of NT-814 in the treatment of common, chronic debilitating female sex-hormone related conditions, with an initial focus on symptoms of the menopause. | ||||||
Dyne Therapeutics is an Antibody-Oligonucleotide Treatments for Muscle Diseases founded in 2018. | ||||||
Promedior is a company founded in 1896 by Jim Broderick. | ||||||
Curetis is a Holzheim am Forst-based molecular diagnostic firm developing tools for diagnostics of infectious disease. | ||||||
A biotechnology company developing immuno-oncology therapies and therapeutic vaccines | ||||||
CatalYm is an innovative immunotherapies developer for cancer patients founded in 2016. | ||||||
Inversago Pharma is a Canadian biotech company at clinical-stage, specializing in the development of new therapies focusing on CB1 blockade. | ||||||
Rigontec GmbH is a biotechnology company and developer of technology for accessing the retinoic acid-inducible gene pathway. | ||||||
Treatment developer for central nervous system (CNS) disorders patient. | ||||||
NewAmsterdam Pharma is a company focusing on the treatment of cardio-metabolic diseases. | ||||||
Developer of monoclonal antibody for immune-mediated inflammatory diseases by targeting Neutrophil extracellular traps (NETs). | ||||||
Innovative therapy provider for cancer and inflammatory disease targeting fibroblast-immune interactions. | ||||||
VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions. | ||||||
Antibody-Drug Conjugate specialist creating treatments for tough-to-treat cancers. |
